Synthesis of radioiodinated 1-deoxy-nojirimycin derivatives: Novel glucose analogs

Nuclear Medicine and Biology

Volumn 26, Issue 7, 1999, Pages 833-839

  Xu, Yiming ^a   Choi, Seok Rye ^a   Kung, Mei Ping ^a   Kung, Hank F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain; Glucose metabolism; Radioiodination; Tumor imaging agents

Indexed keywords

1 DEOXYNOJIRIMYCIN; GLUCOSE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CHROMATOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG BRAIN LEVEL; DRUG SYNTHESIS; ENZYME INHIBITION; GLUCOSE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; IODINATION; NONHUMAN; RADIOCHEMISTRY; RAT; TEMPERATURE; TUMOR DIAGNOSIS;

1-DEOXYNOJIRIMYCIN; ANIMALS; BRAIN; DEOXYGLUCOSE; FLUORODEOXYGLUCOSE F18; GLUCOSE; IODINE RADIOISOTOPES; ISOTOPE LABELING; PIPERIDINES; RADIOCHEMISTRY; RADIOPHARMACEUTICALS; RATS; TISSUE DISTRIBUTION;

EID: 0032758909     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00063-3     Document Type: Article

References (18)

1. Anzeveno P.B., Creemer L.J. Efficient synthesis of (+)-nojirimycin and (+)-1-deoxynojirimycin. Tetrahedron Lett. 31:1990;2085-2088.
2. Asano N., Kizu H., Oseki K., Tomioka E., Matsui K., Okamoto M., Baba M. N-Alkylated nitrogen-in-the-ring sugars Conformational basis of inhibition of glycosidases and HIV-1 replication . J. Med. Chem. 38:1995;2349-2356.
3. Asano N., Nishida M., Kato A., Kizu H., Matsui K., Shimada Y., Itoh T., Baba M., Watson A.A., Nash R.J., Lilley P.M., Watkin D.J., Fleet G.W. Homonojirimycin isomers and N-alkylated homonojirimycins Structural and conformational basis of inhibition of glycosidases . J. Med. Chem. 41:1998;2565-2571.
4. Bashyal B.P., Chow H.-F., Fellows L.E., Fleet G.W.J. The synthesis of polyhydroxylated amino acids from glucuronolactone Enantiospecific syntheses of 2S, 3R, 4R, 5S-trihydroxypipecolic acid, 2R, 3R, 4R, 5S-trihydroxypipecolic acid and 2R, 3R, 4R-dihydroxyproline . Tetrahedron. 43:1987;415-422.
5. Block T.M., Lu X., Platt F.M., Foster G.R., Gerlich W.H., Blumberg B.S., Dwek R.A. Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc. Natl. Acad. Sci. U.S.A. 91:1994;2235-2239.
6. Chida N., Furuno Y., Ikemoto H., Ogawa S. Synthesis of (+)- and (-)-nojirimycin and their 1-deoxy derivatives from myo-inositol. Carbohydr. Res. 237:1992;185-194.
7. Fischer P.B., Collin M., Karlsson G.B., James W., Butters T.D., Davis S.J., Gordon S., Dwek R.A., Platt F.M. The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding. J. Virol. 69:1995;5791-5797.
8. Gatley S.J. Iodine-123-labeled glucose analogs Prospects for a single-photon-emitting analog of fluorine-18-labeled deoxyglucose . Nucl. Med. Biol. 22:1995;829-835.
9. Henry C., Tanti J.F., Gremeaux T., Morin C., Van Obberghen E., Comet M., Le Marchand-Brustel Y. Characterization of 6-deoxy-6-iodo-D-glucose A potential new tool to assess glucose transport . Nucl. Med. Biol. 24:1997;99-104.
10. Karlsson G.B., Butters T.D., Dwek R.A., Platt F.M. Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120. J. Biol. Chem. 268:1993;570-576.
11. Kitahara T., Ogawa T., Naganuma T., Matsui M. Novel synthesis of L-ascorbic acid. Agric. Biol. Chem. 38:1974;2189-2190.
12. Koumanov F., Henry C., Ghezzi C., Bignan G., Morin C., Mathieu J.P., Hamant S., Vidal M., de Leiris J., Comet M. Biological studies of analogues of glucose iodinated in positions 1, 2, or 3. Nucl. Med. Biol. 23:1996;53-60.
13. Kung M.P., Kung H.F., Billings J., Yang Y., Murphy R.A., Alavi A. The characterization of IBF as a new selective dopamine D-2 receptor imaging agent. J. Nucl. Med. 31:1990;648-654.
14. Platt F.M., Neises G.R., Dwek R.A., Butters T.D. N-Butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J. Biol. Chem. 269:1994;8362-8365.
15. Platt F.M., Neises G.R., Karlsson G.B., Dwek R.A., Butters T.D. N-Butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing. J. Biol. Chem. 269:1994;27108-27114.
16. Tsuruoka T., Fukuyasu H., Ishii M., Usui T., Shibahara S., Inouye S. Inhibition of mouse tumor metastasis with nojirimycin-related compounds. J. Antibiot. 49:1996;155-161.
17. Weidmann H., Olbrich G. 1, 2-Isopropyliden-a-D-glucofuranosidurono-5-ulose-6, 3-lacton. Eine beitray zum mechanismus der reduktionswirkung von D-glucofuranosiduronen. Tetrahedron Lett. 1965;725.
18. Wilbur D.S., Hadley S.W., Hylarides M.D., Abrams P.G., Beaumier P.A., Morgan A.C., Reno J.M., Fritzberg A.R. Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer. J. Nucl. Med. 30:1989;216-226.